Caroline MARY

Person

Sainte-Pazanne, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies and polypeptides directed against CD127
- Patent number 11,926,671
- Issue date Mar 12, 2024
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of anti-human SIRPa v1 antibodies and method for producing anti...
- Patent number 11,884,723
- Issue date Jan 30, 2024
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified bifunctional anti-human signal regulatory protein alpha (S...
- Patent number 11,713,356
- Issue date Aug 1, 2023
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating a pathological condition involving the activati...
- Patent number 11,440,964
- Issue date Sep 13, 2022
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-human-PD-1 antibody and its use in cancer treatment
- Patent number 11,352,430
- Issue date Jun 7, 2022
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-SIRPa antibodies and their therapeutic applications
- Patent number 11,279,766
- Issue date Mar 22, 2022
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Non-antagonistic antibodies directed against the alpha chain of the...
- Patent number 11,230,602
- Issue date Jan 25, 2022
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies and polypeptides directed against CD127
- Patent number 11,098,128
- Issue date Aug 24, 2021
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Recombinant monovalent antibodies
- Patent number 10,689,444
- Issue date Jun 23, 2020
- OSE IMMUNOTHERAPEUTICS
- Bernard Vanhove
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against CD127
- Patent number 10,428,152
- Issue date Oct 1, 2019
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD28 humanized antibodies
- Patent number 10,364,287
- Issue date Jul 30, 2019
- Institut National de la Sante et de la Recherche Medicale
- Caroline Mary
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant monovalent antibodies
- Patent number 9,587,023
- Issue date Mar 7, 2017
- OSE IMMUNOTHERAPEUTICS
- Bernard Vanhove
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD28 humanized antibodies
- Patent number 9,562,098
- Issue date Feb 7, 2017
- OSE IMMUNOTHERAPEUTICS
- Caroline Mary
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against the alpha chain of IL7 receptor—their u...
- Patent number 9,447,182
- Issue date Sep 20, 2016
- OSE IMMUNOTHERAPEUTICS
- Sophie Brouard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD28 humanized antibodies
- Patent number 8,785,604
- Issue date Jul 22, 2014
- Effimune
- Caroline Mary
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monovalent ligands of the human CD28 receptor
- Patent number 8,785,138
- Issue date Jul 22, 2014
- Effimune
- Bernard Vanhove
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTI-CHEMOKIN LIKE RECEPTOR 1 ANTIBODIES AND THEIR THERAPEUTIC APPL...
- Publication number 20240400698
- Publication date Dec 5, 2024
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127
- Publication number 20240352135
- Publication date Oct 24, 2024
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SCAFFOLD FOR BIFUNCTIONAL MOLECULES COMPRISING PD-1 OR CD28 AND SIR...
- Publication number 20240182572
- Publication date Jun 6, 2024
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEW SCAFFOLD FOR BIFUNCTIONAL MOLECULES WITH IMPROVED PROPERTIES
- Publication number 20240182571
- Publication date Jun 6, 2024
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL ANTI-PD1/IL-7 MOLECULES
- Publication number 20240067727
- Publication date Feb 29, 2024
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibodies Directed Against CD127
- Publication number 20230340133
- Publication date Oct 26, 2023
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- G01 - MEASURING TESTING
Information Patent Application
ANTI-CLEC-1A ANTIBODIES AND ANTIGEN-BINDING FRAGMENT THEREOF
- Publication number 20230331852
- Publication date Oct 19, 2023
- OSE IMMUNOTHERAPEUTICS
- Elise CHIFFOLEAU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL MOLECULES COMPRISING AN IL-7 VARIANT
- Publication number 20230303648
- Publication date Sep 28, 2023
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-SIRPg Compounds
- Publication number 20230242640
- Publication date Aug 3, 2023
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for Treating CD127-Positive Cancers by Administering an Anti...
- Publication number 20230227565
- Publication date Jul 20, 2023
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VACCINE AGAINST SARS-COV VIRUS
- Publication number 20230181721
- Publication date Jun 15, 2023
- OSE IMMUNOTHERAPEUTICS
- DOMINIQUE COSTANTINI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL ANTI-PD-1/IL-7 MOLECULE
- Publication number 20230071889
- Publication date Mar 9, 2023
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for Treating CD127-Positive Cancers by Administering an Anti...
- Publication number 20220389104
- Publication date Dec 8, 2022
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-HUMAN-PD-1 ANTIBODY
- Publication number 20220332826
- Publication date Oct 20, 2022
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127
- Publication number 20220332834
- Publication date Oct 20, 2022
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS
- Publication number 20220281991
- Publication date Sep 8, 2022
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USES OF ANTI-SIRPg ANTIBODIES
- Publication number 20220242951
- Publication date Aug 4, 2022
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIFUNCTIONAL ANTI-PD-1/SIRPA MOLECULE
- Publication number 20220056135
- Publication date Feb 24, 2022
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL MOLECULE DIRECTED AGAINST HUMAN PD-1
- Publication number 20220025050
- Publication date Jan 27, 2022
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127
- Publication number 20210395376
- Publication date Dec 23, 2021
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMANIZED ANTI-HUMAN-PD-1 ANTIBODY
- Publication number 20210355225
- Publication date Nov 18, 2021
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED ANTI-SIRPA ANTIBODIES AND USES THEREOF
- Publication number 20210179728
- Publication date Jun 17, 2021
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CHEMOKIN LIKE RECEPTOR 1 ANTIBODIES AND THEIR THERAPEUTIC APPL...
- Publication number 20210147558
- Publication date May 20, 2021
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF ANTI-HUMAN SIRPA V1 ANTIBODIES AND METHOD FOR PRODUCING ANTI...
- Publication number 20210040206
- Publication date Feb 11, 2021
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NON-ANTAGONISTIC ANTIBODIES DIRECTED AGAINST THE ALPHA CHAIN OF THE...
- Publication number 20200308288
- Publication date Oct 1, 2020
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEW USES OF ANTI-SIRPg ANTIBODIES
- Publication number 20190382483
- Publication date Dec 19, 2019
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibodies Directed Against CD127
- Publication number 20190382497
- Publication date Dec 19, 2019
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127
- Publication number 20190375844
- Publication date Dec 12, 2019
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEW ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS
- Publication number 20190127477
- Publication date May 2, 2019
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Recombinant Monovalent Antibodies
- Publication number 20170166643
- Publication date Jun 15, 2017
- OSE IMMUNOTHERAPEUTICS
- Bernard Vanhove
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Caroline MARY

Person

Patents Grantslast 30 patents

Antibodies and polypeptides directed against CD127

Use of anti-human SIRPa v1 antibodies and method for producing anti...

Modified bifunctional anti-human signal regulatory protein alpha (S...

Method for treating a pathological condition involving the activati...

Humanized anti-human-PD-1 antibody and its use in cancer treatment

Anti-SIRPa antibodies and their therapeutic applications

Non-antagonistic antibodies directed against the alpha chain of the...

Antibodies and polypeptides directed against CD127

Recombinant monovalent antibodies

Antibodies directed against CD127

Anti-CD28 humanized antibodies

Recombinant monovalent antibodies

Anti-CD28 humanized antibodies

Antibodies directed against the alpha chain of IL7 receptor—their u...

Anti-CD28 humanized antibodies

Monovalent ligands of the human CD28 receptor

Patents Applicationslast 30 patents

ANTI-CHEMOKIN LIKE RECEPTOR 1 ANTIBODIES AND THEIR THERAPEUTIC APPL...

ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127

SCAFFOLD FOR BIFUNCTIONAL MOLECULES COMPRISING PD-1 OR CD28 AND SIR...

NEW SCAFFOLD FOR BIFUNCTIONAL MOLECULES WITH IMPROVED PROPERTIES

BIFUNCTIONAL ANTI-PD1/IL-7 MOLECULES

Antibodies Directed Against CD127

ANTI-CLEC-1A ANTIBODIES AND ANTIGEN-BINDING FRAGMENT THEREOF

BIFUNCTIONAL MOLECULES COMPRISING AN IL-7 VARIANT

ANTI-SIRPg Compounds

Method for Treating CD127-Positive Cancers by Administering an Anti...

VACCINE AGAINST SARS-COV VIRUS

BIFUNCTIONAL ANTI-PD-1/IL-7 MOLECULE

Method for Treating CD127-Positive Cancers by Administering an Anti...

HUMANIZED ANTI-HUMAN-PD-1 ANTIBODY

ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127

ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS

USES OF ANTI-SIRPg ANTIBODIES

BIFUNCTIONAL ANTI-PD-1/SIRPA MOLECULE

BIFUNCTIONAL MOLECULE DIRECTED AGAINST HUMAN PD-1

ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127

HUMANIZED ANTI-HUMAN-PD-1 ANTIBODY

MODIFIED ANTI-SIRPA ANTIBODIES AND USES THEREOF

ANTI-CHEMOKIN LIKE RECEPTOR 1 ANTIBODIES AND THEIR THERAPEUTIC APPL...

USE OF ANTI-HUMAN SIRPA V1 ANTIBODIES AND METHOD FOR PRODUCING ANTI...

NON-ANTAGONISTIC ANTIBODIES DIRECTED AGAINST THE ALPHA CHAIN OF THE...

NEW USES OF ANTI-SIRPg ANTIBODIES

Antibodies Directed Against CD127

ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127

NEW ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS

Recombinant Monovalent Antibodies